Our new publication in JACC helps to optimize ADMERA Health’s CardioGxOne™ test

A new article written by the team of HIC published in The Journal of the American College of Cardiology (JACC) has helped to increase mutation detection rates of Admera Health’s CardioGxOne™ test. Thanks to the addition of the FLNC gene to the main panel, they will be able to evaluate patients with high-risk dilated and arrhythmogenic cardiomyopathies more effectively.

Link to the article: https://www.pm360online.com/category/nasdaq/nasdaq-cardiology-market-news/

Cookies settings
When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. It is worth noting that blocking somo types of cookies may impact your experience on our website.